Related references
Note: Only part of the references are listed.Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma
Christian Freudlsperger et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
M. M. Gerlach et al.
BRITISH JOURNAL OF CANCER (2014)
Radiation Oncology In Vitro: Trends to Improve Radiotherapy through Molecular Targets
Natalia Feofanova et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Increased radioresistance via G12S K-Ras by compensatory upregulation of MAPK and PI3K pathways in epithelial cancer
Annette Affolter et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response
Martynas Drigotas et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2013)
TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence
Heath D. Skinner et al.
CLINICAL CANCER RESEARCH (2012)
The molecular pathogenesis of head and neck squamous cell carcinoma
S. Michael Rothenberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212
Junping Jing et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Cotargeting MAPK and PI3K Signaling with Concurrent Radiotherapy as a Strategy for the Treatment of Pancreatic Cancer
Terence M. Williams et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: A rationale for combination with radiation therapy
Oussama Karroum et al.
RADIOTHERAPY AND ONCOLOGY (2012)
ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE EXTRACELLULAR SIGNAL-RELATED KINASE IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS AFTER IRRADIATION AS PART OF A RESCUE MECHANISM
Annette Affolter et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model
Nichole Renae Dean et al.
ANTI-CANCER DRUGS (2010)
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2010)
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)
Farshid Dayyani et al.
HEAD & NECK ONCOLOGY (2010)
Molecular HPV Typing as a Diagnostic Tool to Discriminate Primary From Metastatic Squamous Cell Carcinoma of the Lung
Wilko Weichert et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
Stephen D. Barrett et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer
Tim J. Kruser et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines
Rebecca Leboeuf et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma
Thomas K. Hoffmann et al.
ORAL ONCOLOGY (2008)
Potent inhibition of thyroid cancer cells by the MEK inhibitor PD0325901 and its Potentiation by suppression of the PI3K and NF-κB pathways
Dingxie Liu et al.
THYROID (2008)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Clinical experience of MEK inhibitors in cancer therapy
Ding Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response
Sarah E. Golding et al.
CANCER RESEARCH (2007)
p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: A novel target of p53 in apoptosis
Sandeep Singh et al.
FEBS LETTERS (2007)
Counting colonies of clonogenic assays by using densitometric software
Maximilian Niyazi et al.
RADIATION ONCOLOGY (2007)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery
N Thompson et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival
S Grant et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin
DL Persons et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Phosphorylation of murine p53 at Ser-18 regulates the p53 responses to DNA damage
C Chao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
